Whitepaper: Neuroinflammation study
Posted: 15 July 2020 | Ncardia | No comments yet
Activated astrocytes that release pro-inflammatory factors have been reported in neurodegenerative diseases. Monitoring neuroinflammation is important for further development of therapeutic treatments. Here we describe how hiPSC-derived astrocytes in combination with HTRF cellular assays offer a robust and physiologically relevant solution to study neuroinflammation pathways.
Related content from this organisation
Related topics
Hit-to-Lead, Imaging, Screening, Stem Cells, Targets
Related organisations
Ncardia